161 related articles for article (PubMed ID: 37614615)
21. 5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines.
Pizzorno G; Cashmore AR; Moroson BA; Cross AD; Smith AK; Marling-Cason M; Kamen BA; Beardsley GP
J Biol Chem; 1993 Jan; 268(2):1017-23. PubMed ID: 8419310
[TBL] [Abstract][Full Text] [Related]
22. Role of N-glycosylation in the structure and function of the methotrexate membrane transporter from CCRF-CEM human lymphoblastic leukemia cells.
Matherly LH; Angeles SM
Biochem Pharmacol; 1994 Mar; 47(6):1094-8. PubMed ID: 8147910
[TBL] [Abstract][Full Text] [Related]
23. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
[TBL] [Abstract][Full Text] [Related]
25. [The expression and functional study of miR-181a in pediatric acute lymphoblastic leukemia].
Liao W; Liu X; Peng H; Xu L
Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):53-7. PubMed ID: 25641148
[TBL] [Abstract][Full Text] [Related]
26. Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
Gangjee A; Devraj R; McGuire JJ; Kisliuk RL
J Med Chem; 1995 Sep; 38(19):3798-805. PubMed ID: 7562910
[TBL] [Abstract][Full Text] [Related]
27. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
[TBL] [Abstract][Full Text] [Related]
28. Role of the E45K-reduced folate carrier gene mutation in methotrexate resistance in human leukemia cells.
Gifford AJ; Haber M; Witt TL; Whetstine JR; Taub JW; Matherly LH; Norris MD
Leukemia; 2002 Dec; 16(12):2379-87. PubMed ID: 12454742
[TBL] [Abstract][Full Text] [Related]
29. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
Aberuyi N; Rahgozar S; Pourabutaleb E; Ghaedi K
Curr Res Transl Med; 2021 Jan; 69(1):103269. PubMed ID: 33071214
[TBL] [Abstract][Full Text] [Related]
30. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation.
Mini E; Stanyon R; Coronnello M; Gerli A; Mazzei T; Periti P
Tumori; 1991 Apr; 77(2):95-9. PubMed ID: 2048234
[TBL] [Abstract][Full Text] [Related]
32. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity of methotrexate and trimetrexate and its reversal by folinic acid in human leukemic CCRF-CEM cells with carrier-mediated and receptor-mediated folate uptake.
van der Veer LJ; Westerhof GR; Rijksen G; Schornagel JH; Jansen G
Leuk Res; 1989; 13(11):981-7. PubMed ID: 2532692
[TBL] [Abstract][Full Text] [Related]
34. Methadone hydrochloride and leukemia cells: Effects on cell viability, DNA fragmentation and apoptotic proteins expression level.
Kua VMD; Rasul A; Sreenivasan S; Rasool B; Younis T; Lai NS
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1797-1803. PubMed ID: 31680075
[TBL] [Abstract][Full Text] [Related]
35. Lipophilic methotrexate conjugates with antitumor activity.
Pignatello R; Spampinato G; Sorrenti V; Di Giacomo C; Vicari L; McGuire JJ; Russell CA; Puglisi G; Toth I
Eur J Pharm Sci; 2000 May; 10(3):237-45. PubMed ID: 10767601
[TBL] [Abstract][Full Text] [Related]
36. Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.
Taylor IW; Slowiaczek P; Friedlander ML; Tattersall MH
Cancer Res; 1985 Mar; 45(3):978-82. PubMed ID: 3971388
[TBL] [Abstract][Full Text] [Related]
37. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
Efferth T; Davey M; Olbrich A; Rücker G; Gebhart E; Davey R
Blood Cells Mol Dis; 2002; 28(2):160-8. PubMed ID: 12064912
[TBL] [Abstract][Full Text] [Related]
38. Loss of tumorigenicity in a methotrexate-resistant human leukemia cell line.
Hill AB; Trent JM; Thompson FH; Danks MK; Beck WT
Cancer Genet Cytogenet; 1993 Oct; 70(1):48-55. PubMed ID: 8221612
[TBL] [Abstract][Full Text] [Related]
39. [The influence of carbohydrate ligands on the cytotoxicity of liposomes bearing a methotrexate-diglyceride conjugate in human acute leukemia cell cultures].
Kuznetsova NR; Gaenko GP; Khaĭdukov SV; Bovin NV; Vodovozova EL
Bioorg Khim; 2009; 35(4):542-9. PubMed ID: 19928057
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of the crude extract and constituents of the bark of Fagara tessmannii towards multi-factorial drug resistant cancer cells.
Mbaveng AT; Damen F; Çelik İ; Tane P; Kuete V; Efferth T
J Ethnopharmacol; 2019 May; 235():28-37. PubMed ID: 30703492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
